Editorial Expression of Concern: Does Cabergoline help in decreasing endometrioma size compared to LHRH agonist? A prospective randomized study

Amr M Salaheldin Abdel Hamid, Wael A. Ismail Madkour, Ashraf Moawad, Mohamed Abd Elzaher, Mary P. Roberts
In: Archives of Gynecology and Obstetrics · 2026 · vol. 313(1) · doi:10.1007/s00404-026-08374-7 · PMID:41784847 · W7133869347
article OA: gold CC0
📄 Open PDF Full text JSON View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by qwen3.7-flash, 2026-09-08 ⓘ

An editorial expression of concern was issued regarding a prospective randomized study that investigated whether cabergoline helps decrease endometrioma size compared to LHRH agonists.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by qwen3.7-flash, 2026-09-08 · read from full text ⓘ

This document is an Editorial Expression of Concern issued by the Editor-in-Chief of the Archives of Gynecology and Obstetrics regarding a previously published study on cabergoline versus LHRH agonists. The concern arises because the authors were unable to provide evidence that the original research received ethical approval prior to its commencement. Two of the authors disagree with this action, while three others have not responded to the publisher's inquiry. This paper does not explicitly discuss endometriosis or adenomyosis; it was included in the corpus via a keyword match in the upstream search index.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Full text 2,708 characters · extracted from oa-pdf · 2 sections · click to expand

Material

in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If

Material

is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http:// creat iveco mmons. org/ licen ses/ by- nc- nd/4. 0/. Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. The original article can be found online at https:// doi. org/ 10. 1007/ s00404- 014- 3242-4. * Amr M. Salaheldin Abdel Hamid [email protected] 1 Obstetrics and Gynecology Department, Ain Shams University, Cairo, Egypt 2 Obstetrics and Gynecology Department, HMC, Abu Dhabi, UAE 3 DGFC, Abu Dhabi, UAE 4 Obstetrics and Gynecology Department, Al Azhar University, Cairo, Egypt 5 EMC, Abu Dhabi, UAE 6 Obstetrics and Gynecology Department, Lifeline Hospital, Abu Dhabi, UAE

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-pdf ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometrioma

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2026) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

SciLite annotations

chemicals 1
cabergoline

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
scilite
last seen: 2026-05-18T04:57:49.680383+00:00
License: CC0 · commercial use OK